The clinical and immunological spectrum of American cutaneous leishmaniasis
- 1 July 1993
- journal article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 87 (4), 444-448
- https://doi.org/10.1016/0035-9203(93)90030-t
Abstract
American cutaneous leishmaniasis is characterized by a spectrum of clinical manifestations. These include localized, often self-healing single lesionKeywords
This publication has 20 references indexed in Scilit:
- Revisiting and revising suppressor T cellsImmunology Today, 1992
- Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector functionImmunology Today, 1991
- Immunocytochemical characterization of immune cells in lesions of American cutaneous leishmaniasis using novel T cell markersActa Tropica, 1991
- Quantitative study ofLeishmania braziliensis braziliensisreactive T cells in peripheral blood and in the lesions of patients with American mucocutaneous leishmaniasisClinical and Experimental Immunology, 1990
- Immunotherapy of Localized, Intermediate, and Diffuse Forms of American Cutaneous LeishmaniasisThe Journal of Infectious Diseases, 1989
- The Relationship of Leishmania braziliensis Subspecies and Immune Response to Disease Expression in New World LeishmaniasisThe Journal of Infectious Diseases, 1989
- Spontaneous healing of cutaneous Leishmania braziliensis braziliensis ulcersTransactions of the Royal Society of Tropical Medicine and Hygiene, 1987
- IMMUNOTHERAPY VERSUS CHEMOTHERAPY IN LOCALISED CUTANEOUS LEISHMANIASISThe Lancet, 1987
- Characterization of the cellular immune response in American cutaneous leishmaniasisClinical Immunology and Immunopathology, 1983
- Specific Inhibition of Lymphocyte-Proliferation Responses by Adherent Suppressor Cells in Diffuse Cutaneous LeishmaniasisNew England Journal of Medicine, 1982